Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens

OBJECTIVE: To investigate, in detail, the effects of rituximab (RTX), an off-label drug for treating multiple sclerosis (MS) disease on preventing and/or ameliorating experimental autoimmune encephalomyelitis (EAE). METHODS: Using bioinformatics analysis of publicly available transcriptomics data, w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Inflamm Res
Autors principals: Al-ani, Mena R, Raju, Tom K, Hachim, Mahmood Y, Hachim, Ibrahim Y, Elemam, Noha M, Guimei, Maha, Bendardaf, Riyad, Maghazachi, Azzam A
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7082624/
https://ncbi.nlm.nih.gov/pubmed/32214838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JIR.S243514
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars